Somatic Genetic Testing Market Report 2026

Somatic Genetic Testing Market Overview

• Somatic Genetic Testing market size has reached to $7.78 billion in 2025 • Expected to grow to $14.92 billion in 2030 at a compound annual growth rate (CAGR) of 13.9% • Growth Driver: Increasing Incidence Of Cancer Fueling The Growth Of The Market Due To Rising Demand For Early And Personalized Diagnosis • Market Trend: Advanced Liquid Biopsy Enables Non-Invasive Cancer Mutation Analysis • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Somatic Genetic Testing Market?

Somatic genetic testing refers to the detailed analysis of genetic mutations that arise in non-reproductive (somatic) cells during a person’s lifetime, most commonly within tumor tissues. This testing plays a crucial role in cancer diagnosis and treatment by identifying specific genetic alterations that can be targeted with personalized therapies, helping to predict disease progression and guide clinical decision-making. The main types of somatic genetic testing are targeted gene panels, whole exome sequencing, whole genome sequencing, carrier screening, and others. Targeted gene panels refer to a genetic testing approach that analyzes a specific group of genes associated with a particular disease or condition, enabling precise and cost-effective diagnosis. This testing utilizes a variety of sample types, including tissue-based, blood-based, bone marrow aspirates, and others, and employs advanced technologies such as polymerase chain reaction (PCR), next-generation sequencing (NGS), microarray, Sanger sequencing, and others. It is used across multiple applications, including cancer diagnosis, cardiovascular disorders, neurological disorders, inherited genetic disorders, and others, serving end users such as hospitals, clinical laboratories, research institutes, at-home testing providers, and others.

What Is The Somatic Genetic Testing Market Growth Forecast?

The somatic genetic testing market size is expected to see rapid growth in the next few years. It will grow to $14.92 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to advancements in ngs and multi-omics technologies, expansion of at-home and clinical sequencing services, increasing precision medicine initiatives, rising government funding for genetic testing programs, integration of ai-based analytics for mutation interpretation. Major trends in the forecast period include rising adoption of targeted gene panels for cancer and rare diseases, increasing use of next-generation sequencing (ngs) technologies, growth in personalized and precision oncology treatments, expansion of at-home genetic testing solutions, integration of multi-omics data for clinical decision-making.

Global Somatic Genetic Testing Market Segmentation

1) By Type: Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Other Testing Methods 2) By Sample: Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples 3) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies 4) By Application: Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Other Applications 5) By End-User: Hospitals, Clinical Laboratories, Research Institutes, Other End-Users Subsegments: 1) By Targeted Gene Panels: Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels 2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing 3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing 4) By Other Testing Methods: Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing

What Is The Driver Of The Somatic Genetic Testing Market?

The increasing incidence of cancer is expected to propel the growth of the somatic genetic testing market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The rising cancer burden is due to lifestyle choices such as poor diet, smoking, physical inactivity, and excessive alcohol consumption. Somatic genetic testing aids in cancer diagnosis by detecting tumor-specific genetic mutations, enabling targeted and personalized treatment approaches. It minimizes invasive procedures by using advanced technologies, improving diagnostic accuracy and patient outcomes. For instance, in November 2023, according to the Canadian Cancer Society, a Canada-based national cancer agency, in 2023, an estimated 239,100 Canadians are expected to be diagnosed with cancer, and approximately 86,700 are projected to die from the disease. Therefore, the increasing incidence of cancer is driving the growth of the somatic genetic testing industry.

Key Players In The Global Somatic Genetic Testing Market

Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., Circulogene Theranostics LLC.

Global Somatic Genetic Testing Market Trends and Insights

Major companies operating in the somatic genetic testing market are focusing on developing advanced diagnostic solutions, such as liquid biopsy tests, to improve accuracy, enable early detection, and reduce the need for invasive procedures. Liquid biopsy tests refer to non-invasive methods that analyze circulating tumor DNA (ctDNA) or other biomarkers in blood samples to detect cancer-related genetic mutations. For instance, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics company, launched the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test, a next-generation liquid biopsy test designed to detect circulating tumor DNA (ctDNA) from blood samples. The SA74-LB is a comprehensive next-generation sequencing (NGS)-based test designed to detect somatic mutations across 74 key cancer-related genes. This test aids in personalized cancer treatment by identifying actionable mutations, monitoring treatment response, and detecting minimal residual disease (MRD) without the need for traditional tissue biopsies. It supports precision oncology, helping guide targeted therapies and monitor disease progression or resistance in real-time.

What Are Latest Mergers And Acquisitions In The Somatic Genetic Testing Market?

In June 2023, Genomenon Inc., a US–based healthcare technology company, acquired Boston Genetics Inc. for an undisclosed amount. With this acquisition, Genomenon aims to intensify its mission to curate the entire human genome by combining its AI-powered Mastermind platform with Boston Genetics’ scientific team, thereby boosting its genomic interpretation capabilities to better support clinical diagnostics and pharmaceutical programs. Boston Genetics Inc. is a US–based genomics interpretation company that specializes in variant curation and annotation using expert genetic scientists.

Regional Insights

North America was the largest region in the somatic genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Somatic Genetic Testing Market?

The somatic genetic testing market consists of revenues earned by entities by providing services such as tumor profiling, biomarker identification, companion diagnostic testing, mutation analysis, and next-generation sequencing (NGS) for personalized cancer therapy selection and treatment monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The somatic genetic testing market also includes sales of testing kits, reagents, assay panels, sequencing instruments, software tools for data analysis, and laboratory consumables used in the detection and interpretation of somatic mutations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Somatic Genetic Testing Market Report 2026?

The somatic genetic testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the somatic genetic testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.